LYTIR

Insider · SEC Form 4 · EXEC. CHAIR & PRINCIPAL OFF

Garo H. Armen

Filed with the SEC as ARMEN GARO H; the order above is the one the filer's own signature uses.

In the 12 months to Nov 8, 2026, on the open market: bought $31K of PTIX. Filed a median of 1 business day after the trade.

Open-market purchases and sales this filer reported on SEC Form 4, by the day traded. Insiders have two business days to file. A sale marked 10b5-1 was made under a plan adopted in advance. How to read these

Insider purchases and sales, by month (last 12 months)Insider purchases: $31K in total; Insider sales: $0 in total.Jul: Insider purchases $5KAug: Insider purchases $26KDecJanFebMarAprMayJunJulAugSepOctNov
Insider purchases above the line: $31KInsider sales below: $0
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.
  1. PTIXBought: Protagenic Therapeutics, Inc.\new Aug 21, 2026 20,000 shares filed Aug 24, 2026 73,533 shares held directly after, as filed filing $13K
  2. PTIXBought: Protagenic Therapeutics, Inc.\new Aug 20, 2026 16,634 shares filed Aug 20, 2026 53,533 shares held directly after, as filed filing $10K
  3. PTIXBought: Protagenic Therapeutics, Inc.\new Aug 19, 2026 2,700 shares filed Aug 20, 2026 36,899 shares held directly after, as filed filing $945
  4. PTIXBought: Protagenic Therapeutics, Inc.\new Aug 11, 2026 2,220 shares filed Aug 12, 2026 34,199 shares held directly after, as filed filing $710
  5. PTIXBought: Protagenic Therapeutics, Inc.\new Aug 6, 2026 685 shares filed Aug 10, 2026 31,979 shares held directly after, as filed filing $151
  6. PTIXBought: Protagenic Therapeutics, Inc.\new Aug 5, 2026 5,000 shares filed Aug 6, 2026 31,294 shares held directly after, as filed filing $1K
  7. PTIXBought: Protagenic Therapeutics, Inc.\new Jul 30, 2026 26,291 shares filed Aug 3, 2026 26,291 shares held directly after, as filed filing $5K

Source: SEC Form 4 filings. Value is shares × the price reported on the filing; a filing whose price failed Lytir's check against the market price is left out, and a trade that related owners reported on separate forms is counted once. Filings can be late, amended or wrong at the source; see methodology.

Other Form 4 entries

Not counted above: entries this filer reported on Form 4 in the same 12 months that are not open-market purchases or sales. Each entry is one line of a filing.

  • AGEN: grant or award (code A), 3 entries, Jun 12 to Jul 10, 2026
Code A
A grant or award from the company, such as stock given as pay.

Source: the same SEC Form 4 filings. The codes are the SEC's own transaction codes; the meanings above are a plain-words reading of the SEC's Form 4 instructions.